Meet the Team
World-class ML PhDs and clinical oncologists working together to transform drug discovery.
Executive Team
J. Deva Reddy
Founder and CEO
With over 25 years in software development and more than a decade in AI, I have founded two AI-driven startups in cancer care and contributed to the discovery and development of oncology-focused drugs. One lesson has remained constant: in complex domains like cancer, we get things wrong more often than we get them right—and progress comes from learning fast and improving continuously. By applying deep expertise in life sciences, oncology, and artificial intelligence, we work to improve prediction accuracy, enable better clinical decision-making, and accelerate the design of more precise cancer therapies. I feel privileged to lead a team driven by scientific rigor, compassion, and a shared commitment to transforming cancer care.
J. Samyukta Reddy
Director – R & D
With 15 years of experience in cancer biology and biochemistry, my work has focused on bridging fundamental science with real-world cancer care. Understanding tumor biology, molecular pathways, and therapeutic response has been central to my journey in oncology and biotechnology. By combining deep biological insight with innovation, we strive to support better treatment decisions and contribute to the development of safer, more effective cancer therapies. I am honored to work with a team committed to translating science into meaningful patient impact.
E. Premkumar Reddy, PhD
Scientific Advisory Board
Dr. E. Premkumar Reddy is a distinguished molecular oncologist and translational scientist with decades of leadership in cancer biology and experimental therapeutics. He is Professor of Oncological Sciences and Pharmacological Sciences at the Icahn School of Medicine at Mount Sinai, New York, and has made foundational contributions to the understanding of oncogenes, cancer signaling pathways, and cell-cycle regulation, enabling the development of targeted oncology therapeutics. He is the founding editor of the journals Oncogene and Genes & Cancer, and a Fellow of the National Academy of Inventors. As a member of the Scientific Advisory Board, Dr. Reddy brings deep expertise in cancer biology, translational research, and drug discovery to guide scientific strategy and innovation.
Dr. Shekar Patil, DM
Scientific Advisory Board
Dr. Shekar Patil is a senior medical oncologist with nearly three decades of experience in comprehensive cancer care. He is a Senior Consultant in Medical Oncology at HCG Cancer Centre, Bengaluru, where he has led the management of complex solid and hematological malignancies using evidence-based, patient-centered approaches. His clinical expertise spans breast cancer, gynecologic malignancies, lymphomas, and leukemias, with extensive experience in advanced systemic therapies including high-dose chemotherapy, concurrent chemoradiation, intraperitoneal chemotherapy, and bone marrow transplantation. As a member of the Scientific Advisory Board, Dr. Patil brings decades of frontline oncology experience to provide strategic guidance, ensuring that scientific innovation and AI-driven solutions remain clinically relevant, safe, and aligned with real-world oncology workflows.
Join Our Mission
We're hiring exceptional scientists and engineers to transform cancer treatment.